GIURATO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.770
AS - Asia 1.168
EU - Europa 742
SA - Sud America 263
AF - Africa 20
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.968
Nazione #
US - Stati Uniti d'America 4.714
SG - Singapore 517
BR - Brasile 211
IT - Italia 208
CN - Cina 202
VN - Vietnam 132
RU - Federazione Russa 123
HK - Hong Kong 121
IE - Irlanda 77
FI - Finlandia 65
DE - Germania 62
BD - Bangladesh 59
GB - Regno Unito 49
JP - Giappone 46
FR - Francia 41
UA - Ucraina 32
IN - India 26
CA - Canada 25
MX - Messico 23
AR - Argentina 21
PL - Polonia 20
NL - Olanda 17
SE - Svezia 16
EC - Ecuador 13
KR - Corea 11
ID - Indonesia 9
CO - Colombia 6
ES - Italia 6
PK - Pakistan 6
IQ - Iraq 5
PY - Paraguay 5
RO - Romania 5
BE - Belgio 4
LT - Lituania 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AT - Austria 3
EG - Egitto 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
TR - Turchia 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
PE - Perù 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MM - Myanmar 1
MV - Maldive 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 6.968
Città #
Wilmington 1.094
Houston 940
Woodbridge 639
Singapore 301
Ashburn 209
Fairfield 188
San Jose 176
Chandler 153
Hong Kong 117
Beijing 98
Seattle 92
Cambridge 76
Council Bluffs 75
New York 71
Dublin 65
Santa Clara 54
Los Angeles 53
Helsinki 49
Ann Arbor 47
Rome 46
Medford 43
Ho Chi Minh City 40
Tokyo 39
The Dalles 38
Hanoi 30
Menlo Park 24
São Paulo 24
Munich 23
Buffalo 22
Chicago 22
Dallas 22
Milan 21
Lawrence 20
North Bergen 20
Colorado Springs 19
Moscow 19
Lauterbourg 18
Jacksonville 17
Warsaw 17
Frankfurt am Main 13
Orem 13
Redondo Beach 13
Rio de Janeiro 11
Shanghai 11
London 10
San Diego 10
Toronto 10
Chennai 9
Denver 9
Mexico City 9
Palo Alto 9
Phoenix 9
Stockholm 9
Salt Lake City 8
Sarno 8
Belo Horizonte 7
Dearborn 7
Miami 7
Monmouth Junction 7
Da Nang 6
Lappeenranta 6
Manchester 6
Montreal 6
Naples 6
Poplar 6
San Francisco 6
Seoul 6
Atlanta 5
Brooklyn 5
Florence 5
Lahore 5
Nuremberg 5
Charlotte 4
Guayaquil 4
Haiphong 4
Hangzhou 4
Querétaro 4
Roubaix 4
Suzhou 4
São José dos Campos 4
Thái Nguyên 4
Amsterdam 3
Baghdad 3
Boardman 3
Bắc Ninh 3
Cincinnati 3
Cleveland 3
Goiânia 3
Gravesend 3
Hưng Yên 3
Lucca 3
Misano Adriatico 3
Montes Claros 3
Mumbai 3
Ninh Bình 3
Novo Hamburgo 3
Quito 3
Riyadh 3
Sorocaba 3
Sterling 3
Totale 5.376
Nome #
Risk of contrast induced nephropathy in diabetic patients affected by critical limb ischemia and diabetic foot ulcers treated by percutaneous transluminal angioplasty of lower limbs 477
Limb Salvage in Patients With Diabetes Is Not a Temporary Solution but a Life-Changing Procedure 432
Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcer 428
Management of negative pressure wound therapy in the treatment of diabetic foot ulcers 422
Non-healing foot ulcers in diabetic patients: General and local interfering conditions and management options with advanced wound dressings 411
Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers 251
Critical limb ischemia: Current challenges and future prospects 238
Rearfoot Transcutaneous Oximetry is a Useful Tool to Highlight Ischemia of the Heel 224
Physician experts in diabetes are natural team leaders for managing diabetic patients with foot complications. A position statement from the Italian diabetic foot study group 221
Endovascular Distal Plantar Vein Arterialization in Dialysis Patients With No-Option Critical Limb Ischemia and Posterior Tibial Artery Occlusion: A Technique for Limb Salvage in a Challenging Patient Subset 205
Recurrence of Critical Limb Ischemia after Endovascular Intervention in Patients with Diabetic Foot Ulcers 203
Limb Salvage in Diabetic Patients With Ischemic Heel Ulcers 202
Diabetes, Lower-Extremity Amputation, and Death. Diabetes Care 2015;38: 1852-1857 198
Osteomyelitis in diabetic foot: A comprehensive overview 197
Peripheral arterial disease in patients with renal-diabetic foot ulcers 188
The Effectiveness of Negative Pressure Therapy in Diabetic Foot Ulcers with Elevated Protease Activity: A Case Series 185
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection 183
Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers 181
Letter Regarding “The Prostacyclin Analogue Iloprost as an Early Predictor of Successful Revascularization in Diabetic Patients Affected by Critical Limb Ischemia and Foot Ulcers” 162
Foot Revascularization Avoids Major Amputation in Persons with Diabetes and Ischaemic Foot Ulcers 135
Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience 121
Effectiveness of Sucrose Octasulfate Dressing in the Treatment of Neuro-Ischaemic Diabetic Foot Heel Ulcers: A Retrospective Single arm Study 120
Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers 99
Hospital Readmission in Patients With Diabetic Foot Ulcers: Prevalence, Causes, and Outcomes 90
Risk Factors for Ulcer Recurrence in Diabetic Patients Managed by an Integrated Foot Care Protocol 90
Microbiological and Clinical Characteristics of Infected Diabetic Foot Ulcers Managed in a Tertiary Level Diabetic Foot Service 89
Early Treatment of Acute Stage 0/1 Diabetic Charcot Foot Can Avoid Major Amputations at One Year 87
Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia 87
Prevalence of Diabetes Mellitus and Clinical Differences in Patients with Severe Osteoporosis and Fragility Fractures 87
Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute Nevelia 86
The Neuro-Ischaemic Charcot Foot: Prevalence, Characteristics and Severity of Peripheral Arterial Disease in Acute Charcot Neuro-Arthropathy 83
Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 81
Bioactive Glass in a Multi Drug Resistance Osteomyelitis in Diabetic Foot: Case Report 80
Diabetic Polyneuropathy and Physical Activity in Type 1 Diabetes Mellitus: A Cross-Sectional Study 80
Diabetic Foot Osteomyelitis in Patients with and without Peripheral Arterial Disease: Two Different Diseases? 76
The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration-A Narrative Review 75
Effectiveness of fast-track pathway for diabetic foot ulcerations 74
Characteristics and outcome for persons with diabetic foot ulcer and no-option critical limb ischemia 71
Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems 66
Prevalence, clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: Comparison between neuropathic and ischemic ulcers 65
Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers 62
Response to the letter of Tariq and colleagues on the paper "below‑the‑ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers" 50
Management of diabetic persons with foot ulceration during COVID-19 health care emergency: Effectiveness of a new triage pathway 48
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)—Rationale and Meta-Analysis of Observational Studies 38
Correction to: Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects 32
Use of Nevelia Dermal-Epidermal Regenerative Template in the Management of Ischemic Diabetic Foot Postsurgical Wounds 31
Diabetic Foot Infections: The Diagnostic Challenges 22
Incidence and causes of major amputation in patients with diabetic foot ulcers: data from a retrospective study 17
Predictive factors of major amputation in patients with diabetic foot ulcers treated by peripheral blood mononuclear cells 10
Metabolic and renal effects of combined SGLT-2 inhibitors and GLP1-R agonists therapy in type 2 diabetes: a real-world analysis across DKD and non-DKD patients 7
Totale 7.167
Categoria #
all - tutte 21.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022231 17 9 26 2 2 24 15 7 11 19 21 78
2022/2023357 20 46 6 43 51 70 37 26 35 1 15 7
2023/2024138 11 3 20 2 9 27 25 4 8 1 5 23
2024/2025862 30 142 73 49 60 121 56 46 59 79 74 73
2025/20262.307 112 201 257 244 232 79 311 198 219 175 145 134
Totale 7.167